Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide.
Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Ascentage Pharma operates in the Biotechnology Research industry and is headquartered in United States.
Ascentage Pharma has approximately 201-500 employees employees.
Ascentage Pharma is based in Suzhou, China, and Rockville, Maryland, United States, United States.
Yes. Ascentage Pharma is a publicly traded company.
You can reach Ascentage Pharma’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.